Cargando…

Commentary: Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression

Detalles Bibliográficos
Autores principales:	Henssler, Jonathan, Bschor, Tom, Baethge, Christopher
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2023
Materias:	Psychiatry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10213966/ https://www.ncbi.nlm.nih.gov/pubmed/37252152 http://dx.doi.org/10.3389/fpsyt.2023.1164471

Ejemplares similares

Meta-analysis overstates benefit of antidepressant combination therapy with α2-antagonists and reuptake inhibitors in major depression
por: Kennedy, Kevin P.
Publicado: (2022)

Commentary: “Consistent Superiority of Selective Serotonin Reuptake Inhibitors Over Placebo in Reducing Depressed Mood in Patients with Major Depression”
por: Fried, Eiko I., et al.
Publicado: (2015)

Hyperthyroidism and clinical depression: a systematic review and meta-analysis
por: Bode, Henry, et al.
Publicado: (2022)

Antipsychotic Withdrawal Symptoms: A Systematic Review and Meta-Analysis
por: Brandt, Lasse, et al.
Publicado: (2020)

Association of the Polygenic Scores for Personality Traits and Response to Selective Serotonin Reuptake Inhibitors in Patients with Major Depressive Disorder
por: Amare, Azmeraw T., et al.
Publicado: (2018)

Maternal Serotonin Reuptake Inhibitor Antidepressants Have Acute Effects on Fetal Heart Rate Variability in Late Gestation
por: Campbell, Kayleigh S. J., et al.
Publicado: (2021)

Initiation of antidepressants in patients infected with SARS-COV-2: Don't forget Caution for “Paradoxical” Anxiety/Jitteriness syndrome—Commentary: Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
por: Bonnet, Udo
Publicado: (2023)

Tumor Necrosis Factor-α Variations in Patients With Major Depressive Disorder Before and After Antidepressant Treatment
por: Yao, Lin, et al.
Publicado: (2020)

Safety and tolerability of edivoxetine as adjunctive treatment to selective serotonin reuptake inhibitor antidepressants for patients with major depressive disorder
por: Martinez, James M, et al.
Publicado: (2015)

Triple Reuptake Inhibitors: The Next Generation of Antidepressants
por: Marks, David M, et al.
Publicado: (2008)

Potential of Antithrombin III as a Biomarker of Antidepressive Effect in Major Depressive Disorder
por: Song, Ruize, et al.
Publicado: (2021)

Five Interpersonal Factors Are Predictive of the Response to Treatment of Major Depression With Antidepressants in Primary Care
por: Salazar-Fraile, José, et al.
Publicado: (2018)

Analysis of the Deleterious Single-Nucleotide Polymorphisms Associated With Antidepressant Efficacy in Major Depressive Disorder
por: Xin, Juncai, et al.
Publicado: (2020)

Association Between Antidepressant Efficacy and Interactions of Three Core Depression-Related Brain Networks in Major Depressive Disorder
por: Wang, Qiang, et al.
Publicado: (2022)

Overstating the consequences of radiographic abnormalities.
por: Flynn, J Jay, et al.
Publicado: (2004)

Serotonin reuptake inhibitor antidepressants (SSRIs) against atherosclerosis
por: Wozniak, Greta, et al.
Publicado: (2011)

Prediction of Selective Serotonin Reuptake Inhibitor Response Using Diffusion-Weighted MRI
por: DeLorenzo, Christine, et al.
Publicado: (2013)

Prescription of selective serotonin reuptake inhibitors in COVID-19 infection needs caution
por: Borovcanin, Milica M., et al.
Publicado: (2022)

Role of Selective Serotonin Reuptake Inhibitors in the Treatment of Hypochondriasis: A Systematic Review
por: Prithviraj, Manoj, et al.
Publicado: (2023)

Lithium Treatment Over the Lifespan in Bipolar Disorders
por: Volkmann, Constantin, et al.
Publicado: (2020)

Modulation of muscarinic system with serotonin-norepinephrine reuptake inhibitor antidepressant attenuates depression in mice
por: Singh, Paramdeep, et al.
Publicado: (2015)

Short- and Long-Term Antidepressant Clinical Trials for Major Depressive Disorder in Youth: Findings and Concerns
por: Safer, Daniel J., et al.
Publicado: (2019)

Antidepressant Treatment-Induced State-Dependent Reconfiguration of Emotion Regulation Networks in Major Depressive Disorder
por: Zhao, Lei, et al.
Publicado: (2022)

A Deep Learning Approach for Predicting Antidepressant Response in Major Depression Using Clinical and Genetic Biomarkers
por: Lin, Eugene, et al.
Publicado: (2018)

Antidepressant effect r TMS during pregnancy in a case of Major Depression Resistant to Pharmacological Treatment
por: Isabel, Martínez-Gras, et al.
Publicado: (2021)

Commentary: Duty to Warn: Antidepressant Black Box Suicidality Warning is Empirically Justified
por: Goodman, Wayne K., et al.
Publicado: (2020)

Candidate genes for antidepressant response to selective serotonin reuptake inhibitors
por: Lotrich, Francis E, et al.
Publicado: (2005)

THERAPY WITH AMINEPTINE, A DOPAMINE REUPTAKE INHIBITOR, IN PATIENTS WITH MAJOR DEPRESSION
por: Channabasavanna, S.M., et al.
Publicado: (1997)

Commentary: Semi-Metric Topology of the Human Connectome: Sensitivity and Specificity to Autism and Major Depressive Disorder
por: Simas, Tiago, et al.
Publicado: (2016)

Is There a Role of Autophagy in Depression and Antidepressant Action?
por: Gassen, Nils C., et al.
Publicado: (2019)

Risk-to-befit ratios of consecutive antidepressants for heavy menstrual bleeding in young women with bipolar disorder or major depressive disorder
por: Zhuo, Chuanjun, et al.
Publicado: (2022)

Selective Serotonin Reuptake Inhibitor (SSRI) Antidepressants, Prolactin and Breast Cancer
por: Ashbury, Janet E., et al.
Publicado: (2012)

Striatal Functional Connectivity Alterations After Two-Week Antidepressant Treatment Associated to Enduring Clinical Improvement in Major Depressive Disorder
por: An, Jing, et al.
Publicado: (2019)

Vasopressin Surrogate Marker Copeptin as a Potential Novel Endocrine Biomarker for Antidepressant Treatment Response in Major Depression: A Pilot Study
por: Agorastos, Agorastos, et al.
Publicado: (2020)

Prescribing behavior of antidepressants for depressive disorders: A systematic review
por: Lam, Mary K., et al.
Publicado: (2022)

Editorial: Alternative treatments to classical antidepressants in treatment-resistant depression
por: Mikellides, Georgios, et al.
Publicado: (2023)

National Prescription Patterns of Antidepressants in the Treatment of Adults With Major Depression in the US Between 1996 and 2015: A Population Representative Survey Based Analysis
por: Luo, Yan, et al.
Publicado: (2020)

The Effectiveness of Selective Serotonin Reuptake Inhibitors for Treatment of Obsessive-Compulsive Disorder in Adolescents and Children: A Systematic Review and Meta-Analysis
por: Kotapati, Vijaya Padma, et al.
Publicado: (2019)

Serotonin Reuptake Inhibitors and the Gut Microbiome: Significance of the Gut Microbiome in Relation to Mechanism of Action, Treatment Response, Side Effects, and Tachyphylaxis
por: Sjöstedt, Peter, et al.
Publicado: (2021)

Optimal Dose of Serotonin Reuptake Inhibitors for Obsessive-Compulsive Disorder in Adults: A Systematic Review and Dose–Response Meta-Analysis
por: Xu, Jiao, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_7isdh901slu1j9npte6q0n3dmh